Out-licensing

We are eager to out-license our Nuntius biotechnology to mRNA players for the development of mRNA vaccines and therapies.

Last news

photo animalerie 1

OST Group becomes a shareholder in July 2019

posted July 08, 2019

Read More

Recent Search Keywords